SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-18-000038
Filing Date
2018-08-09
Accepted
2018-08-09 16:28:38
Documents
82
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20180630x10q.htm 10-Q 2183810
2 EX-31.1 kdmn-20180630xex31_1.htm EX-31.1 19931
3 EX-31.2 kdmn-20180630xex31_2.htm EX-31.2 19952
4 EX-32.1 kdmn-20180630xex32_1.htm EX-32.1 10228
5 EX-32.2 kdmn-20180630xex32_2.htm EX-32.2 10084
  Complete submission text file 0001557142-18-000038.txt   9946425

Data Files

Seq Description Document Type Size
6 EX-101.INS kdmn-20180630.xml EX-101.INS 2473197
7 EX-101.SCH kdmn-20180630.xsd EX-101.SCH 57568
8 EX-101.CAL kdmn-20180630_cal.xml EX-101.CAL 77196
9 EX-101.DEF kdmn-20180630_def.xml EX-101.DEF 303253
10 EX-101.LAB kdmn-20180630_lab.xml EX-101.LAB 441003
11 EX-101.PRE kdmn-20180630_pre.xml EX-101.PRE 465368
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 181005475
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences